DNA Sequencing Market: Global Industry Analysis and Forecast (2021-2027): By Product, Application, Technology, End-User, and Region

DNA Sequencing Market is anticipated to reach US$ 9.17 Bn. by 2027 from US$ 4.80 Bn. in 2020 at a CAGR of 11.4 % during a forecast period. DNA sequencing is a technique for determining the sequence of a DNA molecule in the lab. Using different sequencing techniques available on the market, the arrangement of four nucleotide bases, namely Guanine, Cytosine, Adenine, and Thymine, may be detected. The Human Genome Project was a significant step forward in studying the whole human genome sequence. DNA Sequencing Market 1 To know about the Research Methodology:- Request Free Sample Report The use of DNA sequencing techniques has risen in recent years, thanks to a variety of applications in fields such as medicine, agriculture, forensics, biological research, and others. Starting with Sanger sequencing, the industry is rapidly growing, with millions of sequencing analyses performed every day. This is owing to the field's technical advancements, which have improved the speed, precision, fidelity, and magnitude of sequencing procedures. In the realm of sequencing, next-generation sequencing is the most recent technique. Illumina (Solexa), Roche 454, Ion Torrent, and SOLiD sequencing are some of the most popular NGS technologies on the market. Third-generation DNA sequencing equipment, such as the SMRT and Oxford Nanopore, is now available on the market, measuring the addition of nucleotides to a single DNA molecule in real-time. In the report, 2020 is considered a base year however 2020’s numbers are on the real output of the companies in the market. Special attention is given to 2020 and the effect of lockdown on the demand and supply, and also the impact of lockdown for the next two years on the market. Some companies have done well in lockdown also and specific strategic analysis of those companies is done in the report.

DNA Sequencing Market Dynamics

Growing breeder need for animal and plant reproduction, rising technology and applicable markets, and increasing research and development in the DNA sequencing industry are the primary driving drivers in the global DNA sequencing market. The rising incidence of cancer cases, as well as the entry of new market players, are driving the Global DNA Sequencing Market. Personalized genomics is expected to drive the growth of the DNA sequencing market, as is the growing demand for easy and quick clinical diagnosis, an increase in cancer research activities, high throughput technology, government funding for research activities, and the establishment of various leading companies in DNA sequencing. However, high-cost apparatus, computational problems, duplicate content, professional experience, and ethical concerns are some of the hurdles to the DNA sequencing market's growth. DNA sequencing, a highly accurate and high-throughput method utilized for a range of applications including de novo assembly, WGS, and DNA resequencing, has ushered in a paradigm change in proteomic and genomic research. As a result, various academic research centers have quickly embraced this technology for research projects. In June 2020, Illumina deployed the NovaSeq 6000 Sequencing System at the Whitehead Institute for Biomedical Research in Massachusetts. The market for DNA sequencing is driven by efforts by the Centers for Medicare and Medicaid Services (CMS), the Association for Molecular Pathology, and commercial payers such as Blue Cross Blue Shield and Aetna to increase clinical use of sequencing technology. For example, CMS increased the coverage of NGS-based diagnostic tests for ovarian and breast cancer patients in January 2020, giving patients greater options for personalizing their cancer therapy.

DNA Sequencing Market Segmentation Analysis

By Product, The consumables product sector holds the largest proportion of the DNA sequencing product market, owing to their widespread use and requirement during sample preparation, library formation, and other DNA sequencing-related procedures. Because of the widespread usage of DNA sequencing platforms and the employment of sequencing by synthesis technology in sequencing procedures, the sequencing by synthesis technology segment is expected to dominate the worldwide DNA sequencing market. During the forecast period, pyro sequencing technology is expected to grow at the fastest rate. By Technology, in 2020, next-generation sequencing led the DNA sequencing market, accounting for 58.6 percent of total revenue. The rapid advancements in these technologies, together with the lowering cost of sequencing, have made genome sequencing quicker, more inexpensive, and more precise. Furthermore, with the pandemic of COVID-19 infection, NGS technology is gaining acceptance as a standard clinical diagnostic test, which benefits the segment's revenue share. Third-generation sequencing technologies, such as Nanopore and Single-Molecule Real-Time sequencing, are expected to grow at a significant CAGR in the DNA sequencing market throughout the forecast period. This approach solves the drawbacks of second-generation procedures by allowing for simple sample preparation without the requirement for quicker PCR amplification. It also provides lengthy reads in the hundreds of kilobases range for the discovery of repeated spots in complicated genomes.

DNA Sequencing Market Regional Insight

In 2020, North America dominated the DNA sequencing market, accounting for 44.3 percent of total revenue. North America has the largest share of the DNA sequencing market due to ongoing technical breakthroughs by major companies, significant R&D expenditure, and the availability of technologically sophisticated healthcare infrastructure. Several government initiatives in the United States and Canada promote cancer medication development and therapy research. In the year 2020, the DNA Sequencing market in the United States is expected to be worth US$2.4 billion. The country presently holds 41.4 percent of the worldwide market share. Japan and Canada are two additional prominent geographic markets, with growth forecasts of 8.5 percent and 9.9 percent, respectively, throughout the forecast period. Europe is expected to drive the growth of the DNA sequencing market over the forecast period. Within Europe, Germany is expected to increase at an annual rate of 8.8%, while the rest of the European market is expected to reach US$1.5 billion by the conclusion of the forecast period. Due to the high patient population and growing healthcare infrastructure and spending, the Asia-Pacific market is expected to be the fastest-growing area for the worldwide DNA Sequencing market. Due to growing instances of an older population suffering from cancer, a sedentary lifestyle, and an efficient reimbursement scenario, China, the world’s second-biggest economy, is expected to reach a market size of US$1.3 billion in 2027, representing a CAGR of 17.2% throughout the forecast period.

Report Objectives:

• Landscape analysis of the DNA Sequencing Market • competitive benchmarking • Past and current status of the industry with the forecasted market size and trends • Evaluation of potential key players that include market leaders, followers, and new entrants • Technology trends • Potential impact of micro-economic factors of the market • External and Internal factors affecting market have been analyzed The report also helps in understanding the DNA Sequencing Market dynamics, structure by analyzing the market segments and project the DNA Sequencing Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the DNA Sequencing Market make the report investor’s guide.

DNA Sequencing Market Scope: Inquire before buying

DNA Sequencing Market
Report Coverage Details
Base Year: 2020 Forecast Period: 2021-2027
Historical Data: 2016 to 2020 Market Size in 2020: US $ 4.80 Bn.
Forecast Period 2021 to 2027 CAGR: 11.4 % Market Size in 2027: US $ 10.22 Bn.
Segments Covered: by Product • Consumables • Instruments • Services
by Application • Biomarkers & Cancer • Diagnostics • Reproductive Health • Personalized Medicine • Forensics
by Technology • Sequencing by synthesis • Ion semiconductor sequencing • Sequencing by ligation • Pyrosequencing • Single-molecule-real-time sequencing • Chain termination sequencing • Nanopore sequencing
by End-User • Academic & government research institutes • Pharmaceutical companies • Biotechnology companies • Hospitals & Clinics

DNA Sequencing Market, by Region

• North America • Asia pacific • Europe • Middle East and Africa • South America

DNA Sequencing Market Key Players

• ZS Genetics • Siemens AG • Pacific Biosciences • Myriad Genetics • Microchip Biotechnologies • Johnson & Johnson • Integrated DNA Technologies • Hamilton Thorne Biosciences • Commonwealth Biotechnologies • Bayer Corporation • Agilent Technologies • Abbott Laboratories • Abbott Laboratories • LI-COR Biosciences • GE Healthcare Life Sciences • 454 Life Sciences • Illumina, Inc. • QIAGEN • Perkin Elmer • Thermo Fisher • Macrogen, Inc.

Frequently Asked Questions

1. What is the projected market size & growth rate of DNA Sequencing Market? Ans- DNA Sequencing Market was valued at USD 4.80 billion in 2020 and is projected to reach USD 10.22 billion by 2027, growing at a CAGR of 11.4% during the forecast period. 2. What are the key driving factor for the growth of DNA Sequencing Market? Ans- Growing breeder need for animal and plant reproduction, rising technology and applicable markets, and increasing research and development in the DNA sequencing industry are the primary driving drivers in the global DNA sequencing market. 3. Which Region accounted for the largest DNA Sequencing Market share? Ans- In 2020, North America dominated the DNA sequencing market, accounting for 44.3 percent of total revenue. 4. What makes Asia Pacific a Lucrative Market for DNA Sequencing Market? Ans- Due to the high patient population and growing healthcare infrastructure and spending, the Asia-Pacific market is expected to be the fastest-growing area for the worldwide DNA Sequencing market. 5. What are the top players operating in DNA Sequencing Market? Ans- ZS Genetics, Siemens AG, Pacific Biosciences, Myriad Genetics, Microchip Biotechnologies, and Johnson & Johnson.
1. Global DNA Sequencing Market: Research Methodology 2. Global DNA Sequencing Market: Executive Summary 2.1 Market Overview and Definitions 2.1.1. Introduction to Global DNA Sequencing Market 2.2. Summary 2.1.1. Key Findings 2.1.2. Recommendations for Investors 2.1.3. Recommendations for Market Leaders 2.1.4. Recommendations for New Market Entry 3. Global DNA Sequencing Market: Competitive Analysis 3.1 MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2 Consolidation in the Market 3.2.1 M&A by region 3.3 Key Developments by Companies 3.4 Market Drivers 3.5 Market Restraints 3.6 Market Opportunities 3.7 Market Challenges 3.8 Market Dynamics 3.9 PORTERS Five Forces Analysis 3.10 PESTLE 3.11 Regulatory Landscape by region • North America • Europe • Asia Pacific • The Middle East and Africa • Latin America 3.12 COVID-19 Impact 4. Global DNA Sequencing Market Segmentation 4.1 Global DNA Sequencing Market, By Product (2020-2027) • Consumables • Instruments • Services 4.2 Global DNA Sequencing Market, by Application (2020-2027) • Biomarkers & Cancer • Diagnostics • Reproductive Health • Personalized Medicine • Forensics 4.3. European DNA Sequencing Market, By Technology (2020-2027) • Sequencing by synthesis • Ion semiconductor sequencing • Sequencing by ligation • Pyrosequencing • Single-molecule-real-time sequencing • Chain termination sequencing • Nanopore sequencing 4.4. European DNA Sequencing Market, By End-user (2020-2027) • Academic & government research institutes • Pharmaceutical companies • Biotechnology companies • Hospitals & Clinics 5. North America DNA Sequencing Market (2020-2027) 5.1 North American DNA Sequencing Market, By Product (2020-2027) • Consumables • Instruments • Services 5.2 North America DNA Sequencing Market, by Application (2020-2027) • Biomarkers & Cancer • Diagnostics • Reproductive Health • Personalized Medicine • Forensics 5.3. European DNA Sequencing Market, By Technology (2020-2027) • Sequencing by synthesis • Ion semiconductor sequencing • Sequencing by ligation • Pyrosequencing • Single-molecule-real-time sequencing • Chain termination sequencing • Nanopore sequencing 5.4. European DNA Sequencing Market, By End-user (2020-2027) • Academic & government research institutes • Pharmaceutical companies • Biotechnology companies • Hospitals & Clinics 5.5. North America DNA Sequencing Market, by Country (2020-2027) • United States • Canada • Mexico 6. Asia Pacific DNA Sequencing Market (2020-2027) 6.1. Asia Pacific DNA Sequencing Market, By Product (2020-2027) 6.2. Asia Pacific DNA Sequencing Market, by Application (2020-2027) 6.3. European DNA Sequencing Market, By Technology (2020-2027) 6.4. European DNA Sequencing Market, By End-user (2020-2027) 6.5. Asia Pacific DNA Sequencing Market, by Country (2020-2027) • China • India • Japan • South Korea • Australia • ASEAN • Rest Of APAC 7. Middle East and Africa DNA Sequencing Market (2020-2027) 7.1. Middle East and Africa DNA Sequencing Market, By Product (2020-2027) 7.2. Middle East and Africa DNA Sequencing Market, by Application (2020-2027) 7.3. European DNA Sequencing Market, By Technology (2020-2027) 7.4. European DNA Sequencing Market, By End-user (2020-2027) 7.5. Middle East and Africa DNA Sequencing Market, by Country (2020-2027) • South Africa • GCC • Egypt • Nigeria • Rest Of ME&A 8. Latin America DNA Sequencing Market (2020-2027) 8.1. Latin America DNA Sequencing Market, By Product (2020-2027) 8.2. Latin America DNA Sequencing Market, by Application (2020-2027) 8.3. European DNA Sequencing Market, By Technology (2020-2027) 8.4. European DNA Sequencing Market, By End-user (2020-2027) 8.5 Latin America DNA Sequencing Market, by Country (2020-2027) • Brazil • Argentina • Rest Of Latin America 9. European DNA Sequencing Market (2020-2027) 9.1. European DNA Sequencing Market, By Product (2020-2027) 9.2. European DNA Sequencing Market, by Application (2020-2027) 9.3. European DNA Sequencing Market, By Technology (2020-2027) 9.4. European DNA Sequencing Market, By End-user (2020-2027) 9.5. European DNA Sequencing Market, by Country (2020-2027) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest Of Europe 10. Company Profile: Key players 10.1. ZS Genetics 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Global Presence 10.1.4. Capacity Portfolio 10.1.5. Business Strategy 10.1.6. Recent Developments 10.2. ZS Genetics 10.3. Siemens AG 10.4. Pacific Biosciences 10.5. Myriad Genetics 10.6. Microchip Biotechnologies 10.7. Johnson & Johnson 10.8. Integrated DNA Technologies 10.9. Hamilton Thorne Biosciences 10.10. Commonwealth Biotechnologies 10.11. Bayer Corporation 10.12. Agilent Technologies 10.13. Abbott Laboratories 10.14. Abbott Laboratories 10.15. LI-COR Biosciences 10.16. GE Healthcare Life Sciences 10.17. 454 Life Sciences 10.18. Illumina, Inc. 10.19. Perkin Elmer 10.20. Thermo Fisher 10.21. Macrogen, Inc.

About This Report

Report ID 21790
Category Healthcare
Published Date September 2019
Updated Date Jan 2022
Contact Us